CRA Site Monitoring Report Builder
Convert monitoring observations into FDA-compliant site reports with risk grading
What You Can Do
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
Features
automatically organizes observations into standardized sections (attendance, enrollment, safety review, data quality, protocol deviations, documentation)
categorizes issues as Critical, Major, or Minor with justification and escalation flags
applies ICH-GCP terminology and FDA inspection standard compliance checks
generates actionable items with assigned owners, target dates, and status monitoring
identifies patterns and systemic compliance issues across multiple visits
captures deviation details, root cause analysis, and remediation plans
ensures traceability and documentation sufficiency for regulatory inspections
links adverse events to protocol compliance and monitoring findings
Example Output
Input: Raw notes from site visit including "Patient #23 enrolled 2 weeks late, source data shows dose adjustment not documented, pharmacy inventory variance of 12 units"
Output:
FINDING #1: PROTOCOL DEVIATION — Late Patient Enrollment
Risk Level: MAJOR
Details: Patient #23 enrolled 12 days past protocol-specified window
Regulatory Impact: ICH-GCP 4.8.1 non-compliance
Action Items:
- Sponsor review and patient eligibility assessment (Owner: Dr. Smith, Due: 5 days)
- Amend informed consent if necessary (Owner: Site PI, Due: 10 days)
FINDING #2: DATA INTEGRITY ISSUE — Undocumented Dose Adjustment
Risk Level: CRITICAL
Details: Source documents lack supporting documentation for dose change on [DATE]
Escalation: Immediate sponsor and regulatory notification required
Action Items:
- Retrieve and scan source documents (Owner: Site Coordinator, Due: 2 days)
- Submit corrective action plan (Owner: Sponsor QA, Due: 5 days)
What's Included
- SKILL.md instruction file with skill configuration and usage guidelines:
- Monitoring Report Template: standardized structure for all report sections
- Risk Grading Rubric: criteria for Critical/Major/Minor categorization with FDA alignment
- ICH-GCP Compliance Checklist: validation points for regulatory standards
- Follow-up Action Tracker: template with owner assignment, priority matrix, and status fields
- Site Comparison Framework: multi-visit pattern analysis template
Who It's For
- Clinical Research Associates (CRAs) — conducting site monitoring visits and reporting findings
- Site Monitors — managing multiple trial sites and standardizing documentation
- Clinical Trial Project Managers — aggregating site data and identifying escalation needs
- Regulatory Affairs Specialists — reviewing monitoring reports for FDA compliance
- Quality Assurance teams — auditing site documentation and compliance records
Best For
- Converting raw monitoring visit notes into formal regulatory-compliant reports
- Risk-grading protocol deviations and safety findings for escalation
- Documenting adverse events and protocol compliance issues with audit trail completeness
- Generating corrective action plans and follow-up item tracking
- Preparing site documentation for FDA inspections and regulatory audits
- Identifying systemic compliance patterns across multiple clinical trial sites
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
This skill enables you to automatically audit your websites against compliance standards and detect deviations from expected baselines. You can track regulatory requirements, identify policy violations, and generate compliance reports with actionable remediation steps. Monitor multiple sites simultaneously and maintain detailed audit trails for compliance documentation.
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w